USPTO 2015–2025 USPTO PatentsView US Corporation

Loxo Oncology, Inc.

USPTO PatentsView assignee record - 34 granted patents across 8 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Loxo ranks #9,307 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 8 technology areas.

#9,307
of 49,997 US assignees by volume
Top 43%
by Innovation Score (37.5/100)
20.4
avg claims per patent
+156%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9307 · US Corporation #9,307 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 34 grants
  • UPPER-Q #9,307/49,997
  • PHOTO-FINISH Landscape Structures
  • CPC-NARROW A61K · 8 areas
  • INNOV-THIN 37.5/100
  • CLAIMS-DENSE 20.4 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +156% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Landscape Structures Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Loxo’s 37.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Loxo

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Loxo's Innovation Score is 37.5/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Loxo?

Each dot is one of Loxo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Loxo’s own 20.4 claims/patent is ABOVE the 17.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Loxo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 33.934.034.03434.034.034.1 010203040 Granted patents (volume) Avg claims / patent Landscape Structures Inc. - 34, 13.91Landscape Structu…Leica Microsystems (Schweiz) AG - 34, 11.44Leica Microsystem…Lipoxen Technologies Limited - 34, 18.41LipoxenLodge Manufacturing Company - 34, 1.47Lodge Manufacturi…Lund, Inc. - 34, 18LundLutonix, Inc. - 34, 17.79LutonixLytro, Inc. - 34, 30.09LytroMagnacom Ltd. - 34, 20.59MagnacomLoxo Oncology, Inc. - 34, 20.38Loxo Oncology
Loxo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Loxo's grants concentrate

Loxo Oncology, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 88.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (9 grants) versus a trough of 2 in 2023. By volume, Loxo sits between Landscape Structures Inc. and Magnacom Ltd..

Loxo's three-year grant acceleration

From 2019–2021 to 2022–2024, Loxo Oncology, Inc. moved from 20 to 9 grants (0.45x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Loxo's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Loxo holds 34 patents at rank #9,308, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Loxo

By rank, the assignees closest to #9,308 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Loxo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Loxo, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Loxo ranks #768 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Loxo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 20182019202020212022202320242025 2
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Loxo Oncology, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 3 8.8%
2019 6 17.6%
2020 9 26.5%
2021 5 14.7%
2022 3 8.8%
2023 2 5.9%
2024 4 11.8%
2025partial year 2 5.9%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Loxo Oncology, Inc.'s patent record in context - here's where to go next.

  • Loxo Oncology, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 88.2% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #9,307 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Loxo Oncology, Inc. against Landscape Structures Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 37.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.